ResMed (MEX:RMD) 5-Year Sharpe Ratio : N/A (As of Jul. 01, 2025)

View and export this data going back to 2019. Start your Free Trial

What is ResMed 5-Year Sharpe Ratio?

The 5-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past five years. As of today (2025-07-01), ResMed's 5-Year Sharpe Ratio is Not available.

Competitive Comparison of ResMed's 5-Year Sharpe Ratio

For the Medical Instruments & Supplies subindustry, ResMed's 5-Year Sharpe Ratio, along with its competitors' market caps and 5-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ResMed's 5-Year Sharpe Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ResMed's 5-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where ResMed's 5-Year Sharpe Ratio falls into.

Save Embed

;

Save Embed

;

ResMed 5-Year Sharpe Ratio Calculation

The 5-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset in the last five years. A stock / portfolio's 5-Year Sharpe Ratio can be calculated by dividing the difference between the five-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the investment returns over the past five years.

ResMed (MEX:RMD) 5-Year Sharpe Ratio Explanation

The 5-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past five years. It is calculated as the annualized result of the average five-year monthly excess returns divided by its standard deviation in the five-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

ResMed 5-Year Sharpe Ratio Related Terms

Thank you for viewing the detailed overview of ResMed's 5-Year Sharpe Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

ResMed Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ResMed Inc (MEX:RMD) » Definitions » 5-Year Sharpe Ratio

Comparable Companies

Traded in Other Exchanges

RSMDF:USA RMD:USA 1RMD:Italy 0KW4:UK RME:Germany RMEA:Germany RME:Germany R1MD34:Brazil RMD:Australia RMD:Austria

Address

9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123

Website

https://www.resmed.com

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.